Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Servent

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteriesJustyna Ciolek, Claude Zoukimian, Justine Dhot, et al.
Biomaterials|September 15, 2023
A synthetic delivery vector for mucosal vaccinationAnne Billet, Justine Hadjerci, Thi Tran, et al.
Nature|July 23, 2025
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunctionMathieu Oosterlaken, Angelina Rogliardo, Tatiana Lipina, et al.
Journal of Medicinal Chemistry|July 1, 2020
A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor AgonistsSteve Reynaud, Justyna Ciolek, Michel Degueldre, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteriesJustyna Ciolek, Claude Zoukimian, Justine Dhot, et al.
Biomaterials|September 15, 2023
A synthetic delivery vector for mucosal vaccinationAnne Billet, Justine Hadjerci, Thi Tran, et al.
Nature|July 23, 2025
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunctionMathieu Oosterlaken, Angelina Rogliardo, Tatiana Lipina, et al.
Journal of Medicinal Chemistry|July 1, 2020
A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor AgonistsSteve Reynaud, Justyna Ciolek, Michel Degueldre, et al.
Pageof 10